Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Usefulness of Clot Waveform Analysis-Activated Thromboplastin Time (APTT) for Diagnosing Thrombotic Diseases.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Adjuvant Weekly Paclitaxel and Trastuzumab for HER2-Positive Early-Stage Breast Cancer with Preserved Baseline LVEF: Incidence of Cardiotoxicity and Feasibility of Simplified Cardiac Surveillance.

Breast cancer (Dove Medical Press)·2026
Same author

New insights into JAK2 germline variant-driven stromal cell alterations and proinflammatory bone marrow niche remodeling in myeloproliferative neoplasms.

Leukemia·2026
Same author

Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review.

Journal of clinical medicine·2026
Same author

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Journal of clinical medicine·2026
Same author

Diagnostic and Prognostic Evaluation of Disseminated Intravascular Coagulation Using the Disseminated Intravascular Coagulation Index.

Journal of clinical medicine·2025

相关实验视频

Updated: Jun 21, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K

评估因子VIII度使用凝块波形分析.

Hideo Wada1, Katsuya Shiraki1,2, Takeshi Matsumoto3

  • 1Associated Department with Mie Graduate School of Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-0885, Japan.

Journal of clinical medicine
|July 13, 2024
PubMed
概括

凝块波形分析 (CWA) 显示了因子VIII (FVIII) 试剂活性在不同试验中的变化. 通过CWA-sTT方法,可以更全面地评估FVIII血静能力,特别是对于缩剂.

关键词:
在 APTT 试剂中使用的试剂.在CWA CWA中.欧洲人道法-FVIIIFVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIII FVIIIsTF/FIX测定试验的方法

更多相关视频

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

734

相关实验视频

Last Updated: Jun 21, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

18.9K
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.8K
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

734

科学领域:

  • 生物化学 生物化学
  • 血液学 血液学 血液学
  • 分析化学 分析化学

背景情况:

  • 第八因子 (FVIII) 试剂活性表现出显著的变化,这取决于所使用的试剂和活性部分血栓形成时间 (APTT) 试剂.
  • 评估FVIII试剂的精确静血功能对于有效的血友病治疗至关重要.

研究的目的:

  • 使用凝块波形分析 (CWA) 调查各种FVIII试剂的静血能力.
  • 为了比较通过CWA-APTT,色素测定和CWA-sTT获得的FVIII活动测量.

主要方法:

  • 使用了12种APTT试剂和10种FVIII试剂与参考血 (RP) 进行CWA.
  • 使用CWA-APTT,一种染色体检测,以及CWA-sTT来测量FVIII活动.
  • 在分析中包括了少量组织因子诱导的FIX激活 (sTF/FIXa) 和血时间 (sTT).

主要成果:

  • 在FVIII试剂中,CWA-APTT显示了峰值时间和峰值高度的明显差异,与RP相比,峰值时间和峰值高度通常更短,峰值高度更低.
  • 根据方法,FVIII活动测量有所不同,CWA-sTT的结果比APTT或染色体检测高.
  • 在所有FVIII试剂中,CWA-sTT检测到升高的第二峰值,CWA-sTF/FIXa和CWA-sTT都显示了APTT试剂的增强.

结论:

  • FVIII试剂的静血能力受到APTT试剂的选择的影响.
  • CWA-sTT提供了一种有价值的方法,以进一步评估FVIII度的静血能力,重点关注血栓爆发特征.